已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Anaesthetic depth and complications after major surgery: an international, randomised controlled trial

医学 随机对照试验 外科 麻醉 梅德林 法学 政治学
作者
Timothy G. Short,Douglas Campbell,CHRISTOPHER M. A. FRAMPTON,Matthew T.V. Chan,Paul Stewart Myles,Tomas B. Corcoran,Daniel I. Sessler,GARY H. MILLS,Juan Pablo Cata,Thomas W. Painter,Kelly Patrick Anthony Byrne,Ruquan Han,Mandy H.M. Chu,Davina J. McAllister,Kate Leslie,Mark A. Shulman,Sophie K. A. Wallace,C Farrington,William J. Gallagher,A Ditoro
出处
期刊:The Lancet [Elsevier BV]
卷期号:394 (10212): 1907-1914 被引量:202
标识
DOI:10.1016/s0140-6736(19)32315-3
摘要

An association between increasing anaesthetic depth and decreased postoperative survival has been shown in observational studies; however, evidence from randomised controlled trials is lacking. Our aim was to compare all-cause 1-year mortality in older patients having major surgery and randomly assigned to light or deep general anaesthesia.In an international trial, we recruited patients from 73 centres in seven countries who were aged 60 years and older, with significant comorbidity, having surgery with expected duration of more than 2 h, and an anticipated hospital stay of at least 2 days. We randomly assigned patients who had increased risk of complications after major surgery to receive light general anaesthesia (bispectral index [BIS] target 50) or deep general anaesthesia (BIS target 35). Anaesthetists also nominated an appropriate range for mean arterial pressure for each patient during surgery. Patients were randomly assigned in permuted blocks by region immediately before surgery, with the patient and assessors masked to group allocation. The primary outcome was 1-year all-cause mortality. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12612000632897, and is closed to accrual.Patients were enrolled between Dec 19, 2012, and Dec 12, 2017. Of the 18 026 patients screened as eligible, 6644 were enrolled, randomly assigned to treatment or control, and formed the intention-to-treat population (3316 in the BIS 50 group and 3328 in the BIS 35 group). The median BIS was 47·2 (IQR 43·7 to 50·5) in the BIS 50 group and 38·8 (36·3 to 42·4) in the BIS 35 group. Mean arterial pressure was 3·5 mm Hg (4%) higher (median 84·5 [IQR 78·0 to 91·3] and 81·0 [75·4 to 87·6], respectively) and volatile anaesthetic use was 0·26 minimum alveolar concentration (30%) lower (0·62 [0·52 to 0·73] and 0·88 [0·74 to 1·04], respectively) in the BIS 50 than the BIS 35 group. 1-year mortality was 6·5% (212 patients) in the BIS 50 group and 7·2% (238 patients) in the BIS 35 group (hazard ratio 0·88, 95% CI 0·73 to 1·07, absolute risk reduction 0·8%, 95% CI -0·5 to 2·0). Grade 3 adverse events occurred in 954 (29%) patients in the BIS 50 group and 909 (27%) patients in the BIS 35 group; and grade 4 adverse events in 265 (8%) and 259 (8%) patients, respectively. The most commonly reported adverse events were infections, vascular disorders, cardiac disorders, and neoplasms.Among patients at increased risk of complications after major surgery, light general anaesthesia was not associated with lower 1-year mortality than deep general anaesthesia. Our trial defines a broad range of anaesthetic depth over which anaesthesia may be safely delivered when titrating volatile anaesthetic concentrations using a processed electroencephalographic monitor.Health Research Council of New Zealand; National Health and Medical Research Council, Australia; Research Grant Council of Hong Kong; National Institute for Health and Research, UK; and National Institutes of Health, USA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
眼睛大淇完成签到,获得积分10
2秒前
xx2026完成签到,获得积分10
3秒前
淡淡的凡完成签到 ,获得积分10
4秒前
xx完成签到,获得积分10
4秒前
木子发布了新的文献求助10
5秒前
眼角流星发布了新的文献求助10
5秒前
huohuo2完成签到,获得积分10
7秒前
顺心惜文完成签到 ,获得积分10
7秒前
7秒前
walamobo完成签到,获得积分10
10秒前
huo完成签到,获得积分10
10秒前
11秒前
璐璐发布了新的文献求助10
11秒前
酷波er的应助被阔达的冰露采纳,获得10
12秒前
12秒前
无心的冰绿完成签到 ,获得积分10
13秒前
活力傲柏完成签到,获得积分10
13秒前
13秒前
13秒前
xx2026发布了新的文献求助30
14秒前
xiaoyu完成签到 ,获得积分10
14秒前
阴暗蘑菇完成签到 ,获得积分10
14秒前
huo完成签到,获得积分10
14秒前
15秒前
木子完成签到,获得积分10
15秒前
aaaaassss完成签到,获得积分10
15秒前
16秒前
日尧发布了新的文献求助10
16秒前
17秒前
17秒前
聪明甜桃完成签到,获得积分10
17秒前
Lee完成签到 ,获得积分10
18秒前
传奇3的应助被勤劳的瑀采纳,获得10
18秒前
Kossy.NG完成签到 ,获得积分10
19秒前
人老多情完成签到,获得积分20
19秒前
huo完成签到,获得积分10
19秒前
kk完成签到,获得积分10
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194853
求助须知:如何正确求助?哪些是违规求助? 9580564
关于积分的说明 21871986
捐赠科研通 7794485
什么是DOI,文献DOI怎么找? 3437769
关于科研通互助平台的介绍 2561095
邀请新用户注册赠送积分活动 2484486